Early steps of resistance to targeted therapies in non-small-cell lung cancer

HIGHLIGHTS

• who: Celia Delahaye et al. from the Laboratory of Medical Biology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France Department of Pharmaceutical Sciences, University Paul Sabatier, Toulouse, France have published the article: Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer, in the Journal: Cancers 2022, 2613 of /2022/
• what: The authors focus on EGFR-mutated 5 of 25 non-small-cell lung cancer treated with EGFR-TKI, but the authors also describe similarities in other oncogenic contexts upon targeted therapies or chemotherapies. The studies presented in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.